Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.-Reference-Cited by-同舟云学术

Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.

Published:1981-07 Issue:5 Volume:22 Page:800-810
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Kashyap M L,Srivastava L S,Hynd B A,Gartside P S,Perisutti G

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference36 articles.

1. Lipoprotein structure and metabolism;Jackson;Physiol. Rev.,1976

2. The complete ami no acid sequence of alanine apolipoprotein (apo C-III), an apolipoprotein from human plasma very low density lipoproteins;Brewer;Biol. Chem.,1974

3. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man;Havel;J. Clin. Invest.,1973

4. Role of specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase;Havel;Circ. Res.,1970

5. A specific apoprotein activator for lipoprotein lipase;La Rosa;Biochem. Biophys. Res. Commun.,1970

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship of apolipoprotein C-III proteoform composition with ankle-brachial index and peripheral artery disease in the Multi-Ethnic Study of Atherosclerosis (MESA);Atherosclerosis;2024-08

2. Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-08

3. Systematic Assessment of Protein C-Termini Mutated in Human Disorders;Biomolecules;2023-02-12

4. Identification of substrates of MBL Associated Serine Protease-1 (MASP-1) from human plasma using N-terminomics strategy;Molecular Immunology;2022-11

5. Addressing dyslipidemic risk beyond LDL-cholesterol;Journal of Clinical Investigation;2022-01-04